# TELMISARTAN AND AMLODIPINE
> **ANDA205234** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2016-11-17
## Drug
- **FDA Application Number:** ANDA205234
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TELMISARTAN AND AMLODIPINE
- **Generic name:** TELMISARTAN AND AMLODIPINE
- **Active ingredients:** AMLODIPINE BESYLATE; TELMISARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2016-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205234)
---
*AI Analytics · CC0 1.0*